ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares traded down 5.5% on Friday . The stock traded as low as $1.3601 and last traded at $1.37. 82,350 shares were traded during mid-day trading, an increase of 305% from the average daily volume of 20,327 shares. The stock had previously closed at $1.45.
ImmunoPrecise Antibodies Trading Up 2.9%
The firm has a fifty day moving average price of $1.45 and a 200 day moving average price of $1.38.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
